Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nexlizet
Pharma
Esperion to go private in potential $1.1B buyout by ArchiMed
After a March M&A move of its own, Esperion Therapeutics is itself being acquired and taken private by healthcare investment firm ArchiMed.
Fraiser Kansteiner
May 1, 2026 11:26am
FDA untitled letter skewers Esperion's Nexlizet TV ad
Jan 7, 2026 12:00pm
Esperion campaign sheds light on ‘Lipid Lurkers’ in artery walls
Jul 16, 2024 8:00am
Esperion's new Nexletol analyses build its case with doctors
Nov 13, 2020 11:50am
Esperion launches DTC campaign for Nexletol with all-stock video
Oct 1, 2020 10:40am
Esperion ditches drug launch playbook during pandemic
Sep 21, 2020 11:30am
